Literature DB >> 15012911

A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent.

John G F Cleland1, Christian Torp-Pedersen, Alison P Coletta, Michael J Lammiman.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15012911     DOI: 10.1016/j.eheart.2003.12.001

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  7 in total

1.  Withdrawal from biobank research: considerations and the way forward.

Authors:  Kristina Hug; Göran Hermerén; Mats Johansson
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  A guide to missing data for the pediatric nephrologist.

Authors:  Nicholas G Larkins; Jonathan C Craig; Armando Teixeira-Pinto
Journal:  Pediatr Nephrol       Date:  2018-03-13       Impact factor: 3.714

3.  Addressing missing data in clinical trials.

Authors:  Thomas R Fleming
Journal:  Ann Intern Med       Date:  2011-01-18       Impact factor: 25.391

4.  Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation results.

Authors:  Richard F Potthoff
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

5.  Data retention after a patient withdraws consent in clinical trials.

Authors:  André P Gabriel; Charles P Mercado
Journal:  Open Access J Clin Trials       Date:  2011-04

6.  Empirical evaluation of the need for 'on-going consent' in clinical research.

Authors:  William Smith; Christine Grady; Benjamin Krohmal; Jaime Lazovski; David Wendler
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

7.  The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment.

Authors:  David A Rorie; Robert W V Flynn; Isla S Mackenzie; Thomas M MacDonald; Amy Rogers
Journal:  Trials       Date:  2017-11-23       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.